Daniel James Smith, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus mutans | 18 | 2016 | 139 | 2.960 |
Why?
|
| Dental Caries | 11 | 2016 | 440 | 1.800 |
Why?
|
| Glucosyltransferases | 7 | 2007 | 105 | 1.530 |
Why?
|
| Streptococcal Vaccines | 6 | 2011 | 48 | 1.390 |
Why?
|
| Bacterial Vaccines | 4 | 2005 | 419 | 0.800 |
Why?
|
| Antigens, Bacterial | 7 | 2016 | 1191 | 0.620 |
Why?
|
| Immunoglobulin A, Secretory | 4 | 2016 | 105 | 0.620 |
Why?
|
| Streptococcus sobrinus | 3 | 2007 | 21 | 0.570 |
Why?
|
| Saliva | 8 | 2016 | 800 | 0.560 |
Why?
|
| Antibodies, Bacterial | 7 | 2021 | 1456 | 0.550 |
Why?
|
| Immunity, Mucosal | 7 | 2016 | 485 | 0.470 |
Why?
|
| Bacterial Proteins | 9 | 2013 | 3939 | 0.400 |
Why?
|
| Streptococcal Infections | 4 | 2008 | 644 | 0.400 |
Why?
|
| Immunization | 4 | 2008 | 1276 | 0.360 |
Why?
|
| Biofilms | 3 | 2013 | 626 | 0.340 |
Why?
|
| Immunoglobulin A | 4 | 2021 | 968 | 0.310 |
Why?
|
| Adjuvants, Immunologic | 3 | 2011 | 976 | 0.270 |
Why?
|
| Lectins | 6 | 2016 | 560 | 0.240 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2010 | 1151 | 0.230 |
Why?
|
| DNA, Bacterial | 2 | 2007 | 1529 | 0.230 |
Why?
|
| Carrier Proteins | 6 | 2016 | 5098 | 0.230 |
Why?
|
| Periodontitis | 1 | 2007 | 531 | 0.220 |
Why?
|
| Epitopes | 2 | 2005 | 2647 | 0.210 |
Why?
|
| alpha-Amylases | 1 | 1999 | 39 | 0.180 |
Why?
|
| Enterotoxins | 1 | 2001 | 382 | 0.180 |
Why?
|
| Isoenzymes | 1 | 2004 | 1800 | 0.180 |
Why?
|
| Cholera Toxin | 1 | 2001 | 552 | 0.170 |
Why?
|
| Glucans | 1 | 1998 | 78 | 0.170 |
Why?
|
| Vaccines, Synthetic | 1 | 2001 | 634 | 0.170 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 4490 | 0.150 |
Why?
|
| Pseudomonas Infections | 1 | 2021 | 614 | 0.150 |
Why?
|
| Glycoproteins | 1 | 2005 | 2311 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2005 | 8525 | 0.150 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 957 | 0.140 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 1080 | 0.130 |
Why?
|
| Rats | 7 | 2007 | 24802 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2010 | 3265 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 2246 | 0.120 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 1266 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1134 | 0.120 |
Why?
|
| Peptides | 2 | 2005 | 4388 | 0.120 |
Why?
|
| Peptide Fragments | 2 | 2003 | 5109 | 0.110 |
Why?
|
| Flagellin | 1 | 2011 | 129 | 0.100 |
Why?
|
| Regulon | 1 | 2010 | 71 | 0.100 |
Why?
|
| Vaccines, DNA | 1 | 2011 | 321 | 0.090 |
Why?
|
| Amino Acid Sequence | 4 | 2003 | 14171 | 0.080 |
Why?
|
| Aluminum Hydroxide | 1 | 2007 | 59 | 0.080 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 231 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2003 | 18601 | 0.080 |
Why?
|
| Transformation, Bacterial | 1 | 2006 | 84 | 0.080 |
Why?
|
| Porphyromonas gingivalis | 1 | 2007 | 161 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 180 | 0.070 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 2258 | 0.070 |
Why?
|
| Immunization, Passive | 1 | 2008 | 630 | 0.070 |
Why?
|
| Mouth | 1 | 2008 | 420 | 0.070 |
Why?
|
| Animals | 10 | 2011 | 169277 | 0.060 |
Why?
|
| Administration, Rectal | 1 | 2003 | 71 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 789 | 0.060 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 121 | 0.060 |
Why?
|
| Vaccines, Subunit | 1 | 2003 | 142 | 0.060 |
Why?
|
| Polyglycolic Acid | 1 | 2003 | 420 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 2003 | 505 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2013 | 3064 | 0.050 |
Why?
|
| Sucrose | 2 | 2013 | 184 | 0.050 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2001 | 88 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2003 | 693 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2004 | 1770 | 0.050 |
Why?
|
| Spleen | 1 | 2007 | 2458 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2001 | 458 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2001 | 336 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4889 | 0.040 |
Why?
|
| Immune Sera | 1 | 1998 | 705 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 6276 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2003 | 1118 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2021 | 835 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2016 | 41184 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 1999 | 714 | 0.040 |
Why?
|
| Polymers | 1 | 2003 | 1613 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2016 | 159 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1778 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2003 | 1425 | 0.030 |
Why?
|
| Humans | 13 | 2021 | 715636 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2922 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1489 | 0.030 |
Why?
|
| Cytokines | 1 | 2007 | 7190 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2007 | 13205 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2016 | 1419 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19905 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2006 | 6662 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2212 | 0.020 |
Why?
|
| Female | 6 | 2016 | 377052 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 18774 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 10287 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2010 | 394 | 0.020 |
Why?
|
| Child | 2 | 2008 | 74418 | 0.020 |
Why?
|
| Infant | 3 | 2006 | 34561 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5371 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 440 | 0.020 |
Why?
|
| Gene Order | 1 | 2006 | 182 | 0.020 |
Why?
|
| Streptococcus mitis | 1 | 2005 | 9 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2006 | 823 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 2005 | 127 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2005 | 325 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 3069 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 1132 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2006 | 1278 | 0.010 |
Why?
|
| DNA Primers | 1 | 2006 | 2976 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3945 | 0.010 |
Why?
|
| Male | 3 | 2016 | 350156 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9498 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 13180 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 212228 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 8035 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 13635 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 21802 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 16308 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 7982 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 29270 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 39334 | 0.000 |
Why?
|